Navigation Links
Albireo Has Been Granted Orphan Drug Designation for A4250 from the US FDA for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and for Primary Biliary Cirrhosis (PBC)
Date:11/8/2012

GOTHENBURG, Sweden, November 8, 2012 /PRNewswire/ --

Albireo AB (Gothenburg, Sweden; "Albireo"), a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration ("FDA") for the treatment of

  • Progressive Familial Intrahepatic Cholestasis (PFIC)
  • Primary Biliary Cirrhosis (PBC)

Orphan-drug designation is granted by the FDA to novel drugs that seek to treat a rare disease or condition and provides seven years of market exclusivity for the product upon regulatory approval. Albireo has previously received similar orphan drug designation for the same disease areas from the European Commission.

Orphan designation was granted based on an extensive preclinical data package showing that A4250 has a high potency and a minimal systemic exposure. In addition, substantial benefits were shown in an animal model of cholestasis; the predominant feature of PFIC and PBC.

"We are very pleased with the FDA´s recognition of our technology with A4250 as an orphan medicinal product for the treatment of these liver diseases," said Dr. Hans Graffner, Chief Medical officer at Albireo. "This designation is an important milestone in our efforts to provide a treatment for patients with cholestatic liver diseases; a disease entity often leading to severe symptoms, liver transplantation and with reduced survival. A4250 is an inhibitor of the bile acid transport mechanism and will decrease the toxic levels of bile acids in the liver cells. The approvals of the orphan drug designation for A4250 both in Europe and in the US provide evidence of the quality of the A4250 research and give us confidence to move forward with the development of A4250 in these liver diseases."

About A4250
A4250 belongs to a class of inhibitors of the ileal
'/>"/>

SOURCE Albireo AB
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
2. OncoSec Granted New Patent from China
3. Vomaris patent estate grows to six issued U.S. patents and three granted international patents with U.S. Pat. No. 8,224,439
4. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
5. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
6. QRxPharma Granted Additional US Patent on MoxDuo®
7. BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication
8. Broad Patent Protection Granted for iBio Immunomodulator
9. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
10. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
11. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- Inc. ... for the third straight year, No. 349 in ... exclusive ranking of the nation,s fastest-growing private companies. ... the most important segment of the economy—America,s independent ... Domino,s Pizza, LinkedIn, Zillow, and many other well-known ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro has ... (HITRUST) under its Common Security Framework (CSF). According ... and Privacy Manager, "We appreciate this rigorous, top-to-bottom ... commitment that this certification signifies. Our business partners ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal security ...
(Date:8/21/2014)... Aug. 21, 2014  Zacks.com announces the list of stocks ... Research analysts discuss the latest news and events impacting stocks ... include the Hewlett-Packard (NYSE: HPQ - Free Report ), IBM ... (NYSE: SB - Free Report ), GlaxoSmithKline plc (NYSE: ... (NYSE: FI - Free Report ). Today, ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3ScriptPro Achieves HITRUST Certification 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... 14 Spherix Incorporated,(Nasdaq: SPEX ) reported ... potential,type 2 diabetes drug, Naturlose(R), will expand outside ... of treatment-naive type II,diabetics are being considered. "This ... the first quarter of 2009, which is consistent ...
... a Safe and Effective ... Diabetes Patients, PHILADELPHIA, July 14 GlaxoSmithKline ... Drug Administration (FDA),updated the prescribing information for AVANDIA(R) ... Outcome Progression Trial,(ADOPT), a 4- to- 6 year ...
Cached Medicine Technology:Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S. 2FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years 2FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years 3
(Date:8/23/2014)... Pixel Film Studios, a leader of Final Cut ... ProIntro Vol.3, a customizable title tool for FCPX ... by dragging ProIntro Vol.3 in their timeline" says Christina Austin, ... time saver and i think our users will agree" , ... titles made with Final Cut Pro X users in mind. ...
(Date:8/23/2014)... Youth substance abuse is a serious ... in Houston, TX. Substance abuse can happen to people ... and alcohol dependency in higher numbers than ever before. ... abuse, but don’t know where to find professional youth ... a challenge because most treatment options are designed for ...
(Date:8/23/2014)... August 23, 2014 Summer vacation is almost ... be back in session. While shopping for school supplies and ... weeks, Batzner encourages parents and students to also spend some ... bugs are excellent hitchhikers and thrive in heavily populated places,” ... makes classrooms and dorms the perfect settings for bed bugs ...
(Date:8/22/2014)... 2014 Deep Research Report on ... in-depth research report on the Glucose Meter market. ... Glucose Meter definition, classification, application, and industry chain ... covers the international market analysis, including domestic market ... environment & economic situation analysis. The report on ...
(Date:8/22/2014)... City, UT (PRWEB) August 22, 2014 ... published a new guide on Account-Based Health Plans. , ... plans (ABHPs) as a strategy to lower the cost ... different types of medical spending accounts, however, can be ... comparison chart to learn the four main types of ...
Breaking Medicine News(10 mins):Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3
... 17 Standard & Poor,s will make the,following changes to the S&P 500 ... ) will replace Tribune Co. (NYSE: TRB ) ... Tribune is being taken private in a deal expected ... approvals. -- Salix Pharmaceuticals Ltd. (Nasdaq: SLXP ) will replace Coherent ...
... and insurance status are associated with survival rates among ... in the December issue of Archives of OtolaryngologyHead & ... 10,000 U.S. men and women each year are diagnosed ... to background information in the article. For many years, ...
... New Series ... Michaels," "My Fair Brady ..., Maybe Baby" and "Scott Baio is 46 ... and Pregnant" ... ... VH1 is ringing in 2008 with a full,slate of new premieres and returning series. For ...
... 30 U.S. Ministries for Third Consecutive Year, ... care agency International Aid has been named to,MinistryWatch.com,s ... for,2007. This is the third consecutive year International ... is an online database that reviews the operations ...
... some U.S. hospitals , , MONDAY, Dec. 17 (HealthDay News) ... the pain and anxiety that often follows major surgery, ... acute response was equivalent to a [dose] of morphine, ... Daniel B. Hinshaw, professor of surgery and a member ...
... 17 In an,effort to help prepare ... Corporation and the United Nations Environment Programme,s,North ... a new World,Environment Day partnership and launched ... New Martinsville partner,schools., The International Children,s ...
Cached Medicine News:Health News:Standard & Poor's Announces Changes to U.S. Indices 2Health News:Standard & Poor's Announces Changes to U.S. Indices 3Health News:Study examines factors associated with survival in advanced laryngeal cancer 2Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 2Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 3Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 4Health News:International Aid Named as a MinistryWatch.com 'Shining Light' Christian Ministry 2Health News:Massage Eases Pain, Anxiety After Surgery 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools 3Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools 4
... Our one-of-kind Expander ... solve the problem of ... fit. The Expander Sizer™ ... perfect solution to post ...
For lipoplasty of trochanteric area, abdomen, thighs, hips, buttocks and flanks...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, High Waist, Mid-thigh...
Medicine Products: